Moon, Mars and Minds: Evaluating Parkinson's disease mortality among U.S. radiation workers and veterans in the million person study of low-dose effects.

Authors:
Dauer LT; Walsh L; Mumma MT; Cohen SS; Golden AP and 3 more

Journal:
Z Med Phys

Publication Year: 2023

DOI:
10.1016/j.zemedi.2023.07.002

PMCID:
PMC10919963

PMID:
37537100

Journal Information

Full Title: Z Med Phys

Abbreviation: Z Med Phys

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiotherapy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The content of this article does not necessarily represent the views of the National Council on Radiation Protection and Measurements, Vanderbilt University Medical Center, Memorial Sloan Kettering Cancer Center, U.S. Department of Energy, National Aeronautics and Space Administration, or the U.S. Navy."

Evidence found in paper:

"The National Council on Radiation Protection and Measurements acknowledges the exceptional assistance on dosimetry reconstructions for these MPS cohorts from the Center for Radiation Protection Knowledge at Oak Ridge National Laboratories (Rich Leggett, Caleigh Samuels, Keith Eckerman), Memorial Sloan Kettering Cancer Center (Michael Bellamy, David Bierman) as well as staff support (Kathy Held, President NCRP; Laura Atwell, Director of Operations NCRP). This study, as part of the MPS, was supported in part by a research grant from the 10.13039/100000015U.S. Department of Energy (DOE) (Grant No. DE-SC0008944) awarded to the National Council on Radiation Protection and Measurements, which included interagency support from the U.S. Nuclear Regulatory Commission (NRC), the U.S. Environmental Protection Agency and the National Aeronautics and Space Administration (NASA); and more recent DOE Grants (No. DE-AU0000042 and DE-AU0000046). Additional support included grants from the 10.13039/100005187NRC (NRC-HQ‐60‐14‐G‐0011); the 10.13039/100000030Centers for Disease Control and Prevention (5UE1EH000989, 5NUE1EH001315); 10.13039/100000104NASA (NNX15AU88G, 80NSSC17M0016, 80NSSC17M0016, 80NSSC19M0161), and a Discovery Grant from the Vanderbilt-lngram Cancer Center (Center no. 404-357-9682). Additional funding was received from an 10.13039/100000002NIH/NCI Cancer Center Support Grant (P30 CA008748) awarded to Sloan-Kettering Institute for Cancer Research. Contract support also was received from the 10.13039/100010465Naval Sea Systems Command (N00024-17-C-4322) for dosimetry linkage."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025